90149626 - INSIGNIA

Information

• Trademark
• 90149626

• Source

• Serial Number

  90149626

• Registration Number

  7357841

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  August 31, 2020
  4 years ago

• Registration Date

  April 16, 2024
  8 months ago

• Transaction Date

  April 16, 2024
  8 months ago

• Status Date

  April 16, 2024
  8 months ago

• Published for Opposition Date

  January 02, 2024
  11 months ago

• Location Date

  April 16, 2024
  8 months ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  BAKER, JORDAN A

• Attorney Docket Number

  T-4585 US

  Attorney Name

  Joi A. White

  Law Office Assigned Location Code

  N60

• Owners

  • SpeeDx Pty Ltd

Case File Statements

• DM0000: The mark consists of the word "INSIGNIA" in stylized form.
• GS0051: Pharmaceutical and veterinary preparations and substances for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; enzymes for pharmaceutical, veterinary and medical purposes; medical kits containing medical and/or pharmaceutical preparations and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; clinical diagnostics for medical or veterinary use; biological chemical test kits comprised of reagents and assays for medical laboratory use in analysis that test for the presence of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders
• GS0011: Chemicals used in industry, science, photography, agriculture, horticulture and forestry, except fungicides, herbicides, insecticides, and parasiticides; reagents and reactants for non-medical purposes; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acids for other than medical and veterinary purposes; acids, namely, inorganic acids for industrial purposes; DNA and RNA polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring
• GS0101: Surgical apparatus and instruments; medical and veterinary apparatus and instruments for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; diagnostic testing apparatus and instruments for medical purposes, namely, for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; diagnostic testing kits containing diagnostic testing apparatus for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; point of care medical devices for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; screening kits consisting of medical screening and testing apparatus for the diagnosis of disease, detection and/or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; all of the foregoing excluding heart pacemakers and stethoscopes and orthopedic implants and excluding apparatus, instruments and devices for use with orthopedic surgery and excluding surgical staplers and accessories therefor
• GS0421: Scientific and technological services and research and design relating thereto, in the field of DNA analysis services for scientific research analysis, and scientific research consulting in the field of genetics; scientific genetic research; genetic engineering services for scientific purposes; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry services, namely, chemistry research services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of medical diagnostic apparatus; design of medical diagnostic apparatus; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis and evaluation services for scientific purposes and medical research purposes; DNA and RNA and polynucleic acid and protein sequencing, analysis and evaluation services, for scientific purposes and medical research purposes; genome sequencing services and the analysis and evaluation of data resulting therefrom, for scientific purposes and medical research purposes; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experiments, relating to the results of scientific and medical experiments and tests, relating to the analysis and evaluation of scientific and medical data, and relating to data generated by scientific and medical experiments and tests; scientific and medical research and development services in the field of medical research and genetics; custom design and development of biochemical assays

Case File Event Statements

• 9/3/2020 - 4 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 10/8/2020 - 4 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 1/4/2021 - 3 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 1/5/2021 - 3 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/5/2021 - 3 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 1/5/2021 - 3 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 7/5/2021 - 3 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 7/6/2021 - 3 years ago

  8 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI

• 7/21/2021 - 3 years ago

  9 - ASSIGNED TO LIE Type: ALIE

• 7/21/2021 - 3 years ago

  10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/21/2021 - 3 years ago

  11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/22/2021 - 3 years ago

  12 - SUSPENSION LETTER WRITTEN Type: CNSL

• 7/22/2021 - 3 years ago

  13 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 7/22/2021 - 3 years ago

  14 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 1/20/2022 - 2 years ago

  15 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 7/22/2022 - 2 years ago

  16 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK

• 7/27/2022 - 2 years ago

  17 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC

• 8/8/2022 - 2 years ago

  18 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 8/8/2022 - 2 years ago

  19 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 8/8/2022 - 2 years ago

  20 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 2/14/2023 - a year ago

  21 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/14/2023 - a year ago

  22 - NON-FINAL ACTION E-MAILED Type: GNRT

• 2/14/2023 - a year ago

  23 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 5/12/2023 - a year ago

  24 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 5/12/2023 - a year ago

  25 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/13/2023 - a year ago

  26 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/31/2023 - a year ago

  27 - FINAL REFUSAL WRITTEN Type: CNFR

• 5/31/2023 - a year ago

  28 - FINAL REFUSAL E-MAILED Type: GNFR

• 5/31/2023 - a year ago

  29 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 8/18/2023 - a year ago

  30 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 8/18/2023 - a year ago

  31 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/19/2023 - a year ago

  32 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/21/2023 - a year ago

  33 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 8/21/2023 - a year ago

  34 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 8/21/2023 - a year ago

  35 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 8/21/2023 - a year ago

  36 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 8/21/2023 - a year ago

  37 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/5/2023 - a year ago

  38 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR

• 9/12/2023 - a year ago

  39 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 9/19/2023 - a year ago

  40 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 9/19/2023 - a year ago

  41 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 9/19/2023 - a year ago

  42 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 9/19/2023 - a year ago

  43 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 9/19/2023 - a year ago

  44 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/2/2024 - 11 months ago

  47 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 1/19/2024 - 11 months ago

  48 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA

• 1/23/2024 - 11 months ago

  49 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF

• 12/13/2023 - a year ago

  45 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 1/2/2024 - 11 months ago

  46 - PUBLISHED FOR OPPOSITION Type: PUBO

• 3/11/2024 - 9 months ago

  52 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP

• 2/20/2024 - 10 months ago

  50 - ASSIGNED TO PETITION STAFF Type: APET

• 2/22/2024 - 10 months ago

  51 - CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED Type: CHPB

• 4/16/2024 - 8 months ago

  53 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 4/16/2024 - 8 months ago

  54 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC